{'fraction_non_alphanumeric': 0.01618705035971223, 'fraction_numerical': 0.0017985611510791368, 'mean_word_length': 5.329545454545454, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cerebral aquaporins in an acute mountain sickness model ‐ response to global hypoxia in vivo

Acute mountain sickness (AMS) is a condition with global tissue hypoxia associated with symptoms of increased intracranial pressure. Acetazolamide prophylaxis is used in AMS and has reportedly beneficial effects on cerebral symptoms, underlying mechanism not yet elucidated. The aim of the present study was to examine protein levels of cerebral aquaporins (AQPs) in an experimental model of acute global hypoxia and to study the effect of acetazolamide on AQP1.